Advaxis Inc (ADXS) 11.90 $ADXS Advaxis to Present at the

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Advaxis Inc (ADXS) 11.90 $ADXS

Advaxis to Present at the Cowen and Company 35th Annual Health Care Conference
GlobeNewswire - Mon Mar 02, 6:30AM CST
Advaxis, Inc. (Nasdaq:ADXS), a clinical-stage biotechnology company developing cancer immunotherapies, announced today that Daniel J. O'Connor, President and Chief Executive Officer of Advaxis, will present at the Cowen and Company 35th Annual Health Care Conference being held March 2-4, 2015, at the Boston Marriott Copley Place in Boston, MA.
ADXS: 11.90 (+0.80)

First Week of ADXS October 16th Options Trading
StockOptionsChannel.com - Fri Feb 27, 9:44AM CST
Investors in Advaxis, Inc. saw new options become available this week, for the October 16th expiration.
ADXS: 11.90 (+0.80)

5 Stocks Insiders Love Right Now: GE, Mondelez and More
at The Street - Wed Feb 25, 6:00AM CST
Insiders at these companies have been scooping up shares of their own stock lately.
GE: 25.42 (-0.40), ADXS: 11.90 (+0.80), MDLZ: 35.22 (-1.29), MDGN: 8.35 (+0.17), MDAS: 18.44 (+0.11)

InsiderInsights.com Daily Round Up 2/20/15: GPRO, WMS, TNGO, SONS
InsiderInsights - at Seeking Alpha - Sat Feb 21, 11:18PM CST

TNGO: 12.29 (-0.21), GPRO: 40.13 (-0.95), ADXS: 11.90 (+0.80), GE: 25.42 (-0.40), PNNT: 9.77 (+0.02), SONS: 15.75 (-0.33), WMS: 27.80 (+0.04), JOB: 1.00 (+0.04), BMS: 47.41 (-0.42), GOOG: 567.68 (-7.65), MAS: 25.97 (-0.86), ENT: 13.14 (-0.36), MXWL: 7.23 (-0.44), MSG: 76.05 (-0.94), TSRA: 39.92 (+0.26), CUDA: 38.45 (-0.16), THLD: 4.45 (-0.11), SIX: 45.97 (-0.79), TWTR: 46.75 (-0.60), DATA: 92.34 (-3.16)

Advaxis Surges Higher on Additional Institutional Interest
at The Street - Thu Feb 19, 8:15AM CST
Advaxis stock rallied after a private placement showed added fund participation. Read how this move has rebutted the short thesis.
ADXS: 11.90 (+0.80)

Nasdaq stocks posting largest percentage increases
AP - Wed Feb 18, 5:30PM CST
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at the close of trading:
TTS: 10.82 (-0.13), KNDI: 13.40 (-0.29), ADXS: 11.90 (+0.80), BRDR: 7.34 (-0.20), NERV: 5.34 (-0.24), ANGI: 6.80 (+0.08), SRPT: 13.63 (-0.45), GWGH: 8.18 (+0.18), EGRX: 37.63 (-0.37), Z: 112.52 (-1.95)

Advaxis completes $23M financing
Seeking Alpha - at Seeking Alpha - Wed Feb 18, 12:00PM CST

ADXS: 11.90 (+0.80)

Advaxis Completes $23 Million Financing
GlobeNewswire - Wed Feb 18, 11:15AM CST
Advaxis, Inc. (Nasdaq:ADXS), a clinical-stage biotechnology company developing cancer immunotherapies, announced that it has executed definitive securities purchase agreements with several institutional investors for gross proceeds of approximately $23.0 million in a registered direct offering of approximately 3.1 million shares at a price of $7.50 per share. The pricing on this transaction reflects the at-the-market closing price on February 17, 2015.
ADXS: 11.90 (+0.80)

Advaxis Appoints Mayo Pujols Vice President, Manufacturing
GlobeNewswire - Fri Feb 13, 9:30AM CST
Advaxis, Inc. (Nasdaq:ADXS), a clinical-stage biotechnology company developing cancer immunotherapies, today announced that it has appointed Mayo Pujols as Vice President, Manufacturing. Mr. Pujols brings to Advaxis more than 22 years of experience in global commercial and clinical manufacturing, technology transfer, and product development strategy.
ADXS: 11.90 (+0.80), MRK: 56.84 (-1.14)

Advaxis teams up with Incyte in cervical cancer
Seeking Alpha - at Seeking Alpha - Wed Feb 11, 10:47AM CST

ADXS: 11.90 (+0.80), INCY: 90.00 (-1.97)

Advaxis Forms Clinical Trial Collaboration With Incyte to Evaluate Investigational Combination of Two Novel Cancer Immunotherapies for Early Stage Cervical Cancer
GlobeNewswire - Wed Feb 11, 9:55AM CST
Advaxis, Inc. (Nasdaq:ADXS), a clinical-stage biotechnology company developing cancer immunotherapies, has entered into a clinical trial collaboration agreement with Incyte Corporation (Nasdaq:INCY) to evaluate the combination of Advaxis's Lm-LLO cancer immunotherapy, ADXS-HPV (ADXS11-001), with Incyte's investigational oral indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor, epacadostat (INCB24360). The Phase 2 multicenter, open-label, preoperative window-study will evaluate the safety and efficacy of ADXS-HPV as a monotherapy and in combination with epacadostat in approximately 20 patients with Stage I-IIa human papillomavirus (HPV)-associated cervical cancer.
ADXS: 11.90 (+0.80), INCY: 90.00 (-1.97)

Premarket Gainers / Losers as of 9:10 am
Seeking Alpha - at Seeking Alpha - Wed Feb 11, 8:13AM CST

FCEL: 1.41 (+0.09), ADXS: 11.90 (+0.80), JONE: 8.68 (+0.26), INXN: 29.87 (-0.21), SDRL: 10.55 (-0.39), NBG: 1.43 (-0.08), GNW: 7.67 (+0.06), WBAI: 14.50 (+0.70), PME: 2.52 (-0.03), RAD: 7.65 (-0.03), BLDP: 2.29 (-0.06), BXE: 2.99 (-0.06), PXD: 156.17 (-4.27), ACHN: 11.39 (+0.40), SDR: 4.55 (-0.01), LGF: 32.75 (-0.76), PIR: 11.96 (-0.09), AOL: 40.80 (+0.25), GNRC: 49.14 (-0.56), GOL: 2.99 (-0.12), DCTH: 1.16 (+0.02), CHS: 17.50 (-0.23)

Biotech Stocks Review - Arena Pharma, Amgen, NPS Pharma, ZIOPHARM Oncology, and Advaxis
PR Newswire - Fri Feb 06, 8:00AM CST
Investor-Edge has initiated coverage on the following equities: Arena Pharmaceuticals Inc. (NASDAQ: ARNA), Amgen Inc. (NASDAQ: AMGN), NPS Pharmaceuticals Inc. (NASDAQ: NPSP), ZIOPHARM Oncology Inc. (NASDAQ: ZIOP), and Advaxis Inc. (NASDAQ: ADXS). Free research report on Arena Pharma can be accessed at http://get.Investor-Edge.com/pdf/?c=Arena%20P...amp;s=ARNA. On Thursday, February 05, 2015, the NASDAQ Composite ended at 4,765.10, up 1.03%, the Dow Jones Industrial Average advanced 1.20%, to finish the day at 17,884.88, and the S&P 500 closed at 2,062.52, up 1.03%. The gains were broad based as all the sectors ended the session in positive. The S&P 500 Health Care Sector Index ended the day at 813.68, up 1.64%, with the index also advancing 4.56% in the last three months. Register for your complimentary reports at the links given below.
ADXS: 11.90 (+0.80), ZIOP: 13.38 (-0.43), NPSP: 45.97 (+0.01), AMGN: 154.88 (-4.72), ARNA: 4.32 (+0.09)

Biotech Stock Mailbag: Hep C stocks, Bluebird, Advaxis, Hemispherx
at The Street - Fri Feb 06, 5:05AM CST
Biotech columnist Adam Feuerstein answers readers' questions about health care companies.
BLUE: 113.14 (+0.91), ADXS: 11.90 (+0.80), GILD: 101.81 (-1.61), HEB: 0.25 (-0.01), ACHN: 11.39 (+0.40), MRK: 56.84 (-1.14), ABBV: 55.64 (-1.22)

Lifshitz & Miller Law Firm Announces Investigation of Advanced Photonix, Inc., Advaxis, Inc., Advent Software, Inc., Books-A-Million, Inc., City National Corporation, Energy Recovery, Inc., and NetScout Systems, Inc.
PR Newswire - Wed Feb 04, 9:46AM CST
Advanced Photonix, Inc.
BAMM: 2.62 (+0.06), API: 0.41 (+0.01), LUNA: 1.38 (-0.07), ADXS: 11.90 (+0.80), NTCT: 41.82 (-0.15), ADVS: 44.05 (-0.07), CYN: 89.25 (-0.36), ERII: 2.79 (-0.47)

MarketExclusive.com - H.C. Wainwright & Co. Reiterates BUY Rating of Advaxis Inc. and Reports Encouraging Updates on ADXS-HPV Programs
ACCESSWIRE - Wed Feb 04, 9:44AM CST
New York, NY / ACCESSWIRE / February 4, 2015 / Market Exclusive announces that H.C. Wainwright & Co has reported on encouraging updates on Advaxis Inc.'s (Nasdaq:ADXS) ADXS-HPV programs presented at the company's investor day on February 3, 2015. H.C. Wainwright & Co. continues to rate the shares of Advaxis as Buy with a 12-month price target of $14.00 per share.
ADXS: 11.90 (+0.80)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

A&G Management's Bold New Era with WPM Partnership

Updated Category News Views 6

Shaking Up Baltimore's Real Estate Scene Swapping up management partners can be a dicey game, but A&G Management seems to be pulling it off without a hitch. As of January 4, 2027, WPM Real Estate Management will take over the reins for more than 3,000 apartment homes scattered across Anne Arundel, Howard, and Baltimore counties. A new set of hands is stepping in for...

Continue Reading
Sungrow's Keeper Family: Revolutionizing C&I Energy Storage

Updated Category News Views 109

The Next Level in Energy Storage Solutions Well, folks, Sungrow's got something up its sleeve that's shaking up the energy storage scene. They're calling it the 'Keeper Family,' and if you’re deep into commercial and industrial (C&I) energy storage, this might just be your ticket to topping those profit charts. Launched at the Global Energy Pioneer Summit 2026, their...

Continue Reading
Gary Brecka's Longevity Centers Set to Launch with Impact

Updated Category News Views 84

A Footprint of Longevity in the Making It's not every day you see a name like Daymond John, of Shark Tank fame, getting his hands into the business of human longevity. But here we are, with Gary Brecka's Ultimate Longevity Center (ULC) getting ready to open its first centers come January 2027, in Arizona, Colorado, Florida, and Southern California. More than 300 U.S....

Continue Reading
Nevada Expands Rural Youth Mental Health Access

Updated Category News Views 129

Nevada's Rural Mental Health Crisis When you're navigating the barren stretches of rural Nevada, the scenic views can be breathtaking. But for many families, finding basic services like mental health care is as challenging as striking water in the desert. Cartwheel Care has taken the bull by the horns with their latest initiative to bridge this glaring gap. Partnering...

Continue Reading
China's APEC Summit: A Catalyst for Business Growth?

Updated Category News Views 92

A Shift Toward Regional Stability China's position as this year's APEC rotating chair presents both opportunity and challenge as economies grapple with trade barriers and technological upheaval. The 33rd APEC Economic Leaders' Meeting in Shenzhen is intended to navigate these turbulent waters, setting the stage for a more stable regional environment. APEC's Role in...

Continue Reading
Bizzdesign Tops Gartner’s 2026 Enterprise Architecture List

Updated Category News Views 78

Enterprise Architecture’s Silent Backbone Sometimes it's the quiet operators like Bizzdesign that hijack the spotlight after years of steady steering. With the latest nod from Gartner, Bizzdesign is clearly on a tear in the enterprise architecture domain. In their 2026 Critical Capabilities report, Bizzdesign's products—Horizzon, Alfabet, and Hopex—secured top spots...

Continue Reading
SOBER CAFFEINE™: Modern Energizer Without the Bull

Updated Category News Views 135

Shed the Cans and Embrace Convenience I'm sure you've had a run-in with the standard energy drink routine. You know, the massive cans, a gut punch of sugar, and the inevitable crash that follows? Sobriety Supplements LLC decided enough is enough and rolled out something that just makes sense—SOBER CAFFEINE™ capsules. This little pill is a godsend for folks sick of...

Continue Reading
WHP Global's Japan Move: A Major Toy Market Play

Updated Category News Views 20

New Horizons for Toys"R"Us in Japan Well, folks, look who's back in the toy game with a vengeance! WHP Global is shaking hands with Pan Pacific International Holdings (PPIH) to breathe new life into Toys"R"Us across Japan. Now PPIH isn’t just any player. We're talking about Japan's fourth-largest retailer, helming giants like Don Quijote and aiming to crown itself as...

Continue Reading
Christian Faith: Navigating Spiritual Pitfalls Wisely

Updated Category News Views 74

Taking a Deep Look at Christian Faith If you think faith is as simple as saying a few prayers and checking church attendance off the list, well, think again. G. Joseph Johnson, in his thought-provoking tome "Roads, Ditches, Traps, and Snares," believes that faith is a journey filled with twists, turns, and yes, a few traps. This book is a sort of roadmap for Christians,...

Continue Reading
Mall of America Strives for World Record This Black Friday

Updated Category News Views 128

History in the Making at Mall of America Yeah, it seems these folks are not just about shopping anymore. The Mall of America is aiming to set the bar high this Black Friday, eyeing a GUINNESS WORLD RECORDS title for the most people holding up the same shopping bag all at once. Imagine a thousand people, synchronized like a flash mob—only with shopping bags instead of...

Continue Reading

Top 5 Most Recently Viewed Articles

Anticipating Greenlight Capital Re's Q4 and Annual Results

Updated Category News Views 139

Greenlight Capital Re, Ltd. Plans Future Financial Release Greenlight Capital Re, Ltd. (NASDAQ: GLRE), a leading multiline property and casualty insurer and reinsurer, has announced its schedule for releasing financial results for the fourth quarter and full year, which ended on December 31, 2024. The company is set to disclose these important results after the market...

Continue Reading
Integral Ad Science Holdings Faces Shareholder Lawsuit Insights

Updated Category News Views 125

Integral Ad Science's Shareholder Alert Integral Ad Science Holding Corp. (NASDAQ: IAS) is currently grappling with a significant legal challenge. A class action lawsuit has been filed against the company, alerting shareholders of their rights and options. Investors linked to the company should be aware of these developments as they navigate their positions in the market....

Continue Reading
Corcoran Expands Internationally with New Franchise Launch

Updated Category News Views 145

Corcoran Launches New Franchise in Mexico Corcoran Group LLC has taken a significant step in its expansion strategy by announcing the launch of its first franchise in Mexico, named Corcoran The Baja Real Estate Co. Led by Blake Harrington, this new brokerage is set to serve clients in the vibrant area surrounding Cabo San Lucas. This strategic move underscores Corcoran's...

Continue Reading
Titan Mining Announces Details for Upcoming AGM Meeting

Updated Category News Views 263

Titan Mining Corporation's Upcoming Annual General Meeting Titan Mining Corporation (TSX: TI; OTCQB: TIMCF) is set to hold its annual general meeting soon, a much-anticipated event for shareholders and stakeholders alike. The date is indeed significant as it marks an opportunity for the company to engage directly with its investors. Meeting Details and Importance The...

Continue Reading
Investing in EQT: A 20-Year Journey of Growth and Returns

Updated Category News Views 182

Understanding EQT Corporation's Investment Landscape EQT Corporation (NYSE: EQT) has shown substantial growth in the investment landscape over the past two decades. Over this period, EQT has consistently outperformed the market by 10.28% on an annualized basis, resulting in an impressive average annual return of 18.48%. This growth has contributed to EQT's current market...

Continue Reading